Australian (ASX) Stock Market Forum

IMM - Immutep Limited

Jump to new
O

ozewolf

Joined
8 March 2005
Posts
48
Reactions
0
PRR is definitely worth looking into...check out their site...

I believe that PRR will add value to shareholders over the next upcoming weeks...

PRR is just another tip of mine, keeping in mind that HDR and most recently CPC had good returns to shareholders since I've mentioned...

Good luck all...

Looking at current competition, I think most of you need going north...

Ozewolf






:)
 
Re: PRR

Hi All,

Below latest on PRR...and still confident that this stock is going sharply north by end 05.

Ozewolf




COMPANY ANNOUNCEMENT
US Walter Reed Army Institute of Research signs R&D Agreement
with Prima and Austin Research Institute
Tuesday 18 October, 2005 Melbourne, Australia. Prima Biomed (ASX:pRR, ?Prima?) is pleased to
announce that the US Army Walter Reed Army Institute of Research (?WRAIR?) has signed a
Cooperative Research and Development Agreement (CRADA) with its subsidiary Panvax Ltd and the
Austin Research Institute (ARI), to include the DCtag? vaccine adjuvant technology in the
development of a novel malaria vaccine.
The joint research program, between WRAIR and ARI, which the parties plan to secure NIH funding to
complete, will test the ability for DCtag
TM
conjugated to WRAIR?s proprietary malaria antigens to
protect against malaria infections, initially in animal models. DCtag
TM
elicits dendritic cell activity and
subsequent stimulation of potent humoral (B-cells, antibodies) and cell mediated (CD8 & CD4 T-cell)
immune responses, both of which are required to prevent a malaria infection.
?Alternative vaccines under development around the world generally stimulate CD8 T-cells or
antibodies, not both. The transferability of the DCtag
TM
technology to potentially any cancer or
infectious disease antigen makes it an extremely exciting technology. Prima is focusing internal
development of DCtag
TM
in cancer and the opportunity to collaborate with the WRAIR in malaria
vaccines aligns to our strategy of partnering DCtag
TM
development in the infectious diseases area?
said Marcus Clark, CEO Prima.
Malaria remains highly relevant to the military because of its prevalence, variety, debilitating nature,
potential lethality, and tendency to become resistant to drugs. No organization in the world has
WRAIR's experience in the complete spectrum of malaria research. WRAIR has been successful in
developing and field testing antimalarial drugs. Because there is still no effective malaria vaccine,
WRAIR is actively pursuing research and development for a vaccine that will protect U.S. military
personnel in regions of the world where malaria is endemic. Approximately 40% of the world's
population, mostly those living in the world's poorest countries, is at risk of malaria. Malaria is found
throughout the tropical and sub-tropical regions of the world and causes more than 300 million acute
illnesses and at least one million deaths annually.
In 1999, the malaria market was estimated to be US$100 to 150 million per year by the
pharmaceutical industry.1 Although the opportunity for revenue may be limited to travellers from the
developed world, it is also beneficial in terms of DCtag? infectious disease proof of concept.
"Mr. Clark said, "The signing of this R&D collaboration by the largest and most diverse biomedical
research laboratory in the U.S. Department of Defense is a strong indication of the DCtag technology's
breakthrough potential in the world-wide search for a malaria vaccine."
Prima has secured rights to commercialise the resultant technology worldwide, excluding WRAIR?s
right to use the vaccine for US government purposes. Prima will seek a licensing partner to develop
the vaccine for the worldwide market which is consistent with the Prima Board?s strategy to partner
development of its infectious disease portfolio.
As recently announced, the future success of Prima lies in the commercialisation of cancer
technologies, Panvax is developing the DCtag
TM
technology as an immune stimulant to enhance the
treatment of cancer.
1 Medicines for Malaria Venture 1999 http://hopkins-id.edu/tb_rpt/report_07.html


:) :) :)
 
:)

Hi folks,

Long-term PRR chart tells it all, really ..... :)

Click here for longer-term PRR chart ..... :)

Reasoning goes like this:

05022002 hi = .72 cents and 16032006 low = .072 cents
..... a drop of exactly 90% from the highs.

05022002 =====>>> 16032006 = 1500 calendar days

1500 days = harmonic of current Jupiter transit for PRR,
so significant news expected here.

In the long-term chart, the expected recovery rate
will see us with a retracement target, at 39.5 cents,
on 04 April 2008.

-----

Triple bottom, since first low made, around 4th
anniversary of the high in 2002 ... see attached chart.

Monday should usher in 3 significant time
cycles for PRR, plus another aspect involving
Jupiter = big changes???

Our other technical indicators have already turned
up and our not-so-technical, contrarian indicators
tell us there's a lot of interest in this vessel,
albeit from those who were burnt, as she settled
on the bottom ..... :)

=====

happy trading

yogi


:)
 

Attachments

  • PRR24032006zoom.gif
    PRR24032006zoom.gif
    38.1 KB · Views: 311
:)

Hi folks,

PRR ... its working, she's lifting up nicely ..... !~!

..... and not much ballast showing below 10 cents,
right now ..... :)

happy days

yogi

:)
 
PRIMA undersold...

PRIMA FPO (PRR) is in my opinion a Stock worth looking at...
At current price levels a must consider. PRIMA has a lot going for, especially with positive NEWS to be released first quarter.

Must check out their website !!

Ozewolf ;)
 
Re: PRIMA undersold...

ozewolf said:
PRIMA FPO (PRR) is in my opinion a Stock worth looking at...
At current price levels a must consider. PRIMA has a lot going for, especially with positive NEWS to be released first quarter.

Must check out their website !!

Ozewolf ;)
Click to expand...

Ozewolf,

You plugged this stock back in Oct 05 when it was around 10c. It's now down to half that price and you've just plugged it again.

Are we looking at the same chart..? It's hasn't even reached a sideways/stage 1 trend yet. It's still in Stage 4/downtrend.

As for their website,,who give a rats about it. It's the SP we're worried about.
 
Novski,

I know it was back in 05...however good news re Prima's performances
will start to reflect as a positive in first quarter 07, meaning that I am still bullish about this stock...
Have a good look at their site and read what's cocking.

Current price is way under and I believe that this one will heat up and start to show a lot of interest by April 07 latest...

A takeover (Peptech ?) wouldn't take me by surprise...

Ozewolf ;)
 
ozewolf said:
good gain and volume today...
anyone noticed ?

Ozewolf :)
Click to expand...

Yes mate, but i don't get excited with this because i've lost count the amount of times it's done this and gone straight back down, lower and lower.

Until the price gets above the 210 Day MA and the MA is clearly ascending, I'm not even thinking about it.
 
Hi there,

You sound you got burned,
the game is to buy low and cash in at 30% up.

Now could be the time since there is a bid of a bio hype happening...

Ozewolf :)
 
Yes ozewolf, i have been burned by this one and what i've learned from it is, never try and predict the bottom, as many newbie's do. As has been said many times, trying to predict the bottom, is like trying to catch a falling knife.

If trying to predict the bottom and selling after 30% is your plan, then go for it. That's not in my plan.

There does seem to be a bit of a bio surge nevertheless. Will be interesting to see if it's the start of something more long term...
 
Man you seen it now?

6.3c

Announcement - "Australian Patent for Treating Cancer with Antibodies"

I wonder whats this worth to the company?
 
Only up + 300 % in a day :D. They're out of cash and their only hope until recently was to sell their intellectual property or pray for some venture capital mob to buy them out. With today's rise the game could change a bit though...
 
lol i think its funny that there is a total of 157,227,158 OS and ~201m got traded today...Def waiting to next patent release.
 
Prima receives Australian Patent for Methods of Treating Cancer with Antibodies

Tuesday, 14th August, Melbourne, Australia: Prima Biomed Limited (ASX: PRR) today announced that an Australian Patent has been granted to it providing proprietary rights to the therapeutic application of anti-cancer antibodies targeting the tumour antigen, cripto-1.

Prima has also recently received a notice of allowance in a corresponding US patent application, which is expected to issue as a patent in due course.

This is an important outcome for the company with this technology as there is international competition for cripto-1 antibodies and the granting of the patent clearly defines the broad scope of Prima’s protection.

The patent titled, Antibodies Against Cancer, Patent Number 2002240719, claims priority from 26 March 2001 and has an expiry date of 26 March 2022. The patent describes antibodies that target cripto-1, a tumour marker that is over-expressed in cancer cells, making it an attractive target for therapy. The antibodies described in the patent have been shown to inhibit tumour cell growth and induce apoptosis (cell death) in cancer cells. The antibodies work synergistically with chemotherapy agents offering improved cancer cell killing.

In 2003, Prima’s wholly owned subsidiary Oncomab Pty. Ltd., entered into an agreement with Medarex Inc (USA) to develop human antibodies to cripto-1 after promising levels of anti-tumour activity were demonstrated with prototype, rat-based antibodies. Medarex and Oncomab have recently completed the first stage of preclinical in vivo analysis of the human antibodies.

The grant of the patent in Australia is the second to be granted in the patent family with prosecution continuing in all other key territories. The first grant of the patent was in New Zealand.



WOW, what an increase! Over 300%. Spectacular.

:eek:

No one got that for the August stock picking contest!
 
Well this is up again today, I'm amazed...this is going upstream and doing it well... what a funny time for this baby to rocket..
 
Hard to tell, especially with current fluctuations, but I don't think that we're to far off seeing this stock @ 0.08 - 0.10...:)

Still don't get it why this Stock is so brutaly pushed down at end of days trading...:banghead:
 
ozewolf said:
Hard to tell, especially with current fluctuations, but I don't think that we're to far off seeing this stock @ 0.08 - 0.10...:)

Still don't get it why this Stock is so brutaly pushed down at end of days trading...:banghead:
Click to expand...

Directors sold up the day after announcement.:mad: (Check ASX anns).
I also saw on the news that there is now a vaccine available to prevent infection from the virus that causes cervicale cancer.
I bought some @ .3 and sold after I heard this news @ .48
 
PRR is developing a treatment for ovarian cancer, which is completely different from cervical cancer. The anouncment about the new cervical cancer vaccine should have no effect on PRR as preventing cervical cancer has no effect on the rate of ovarian cancer, particularly given that Gardasil, the other HPV vaccine, has been on the market for over a year now.

The slump in share price has more to do with Eugene Kopp offloading his shares - it is difficult to have confidence in a company that a director is looking to get out of. At the same time two other major shareholders also dumped - because suddenly there was some profit to be had out of a company that in its last report basically stated that it didn't have the capital to continue developing its products, and it was looking for a takeoever offer or selling some of its intellectual property.

I think this is a shame because they do have some good potential with what they have developed so far - but I don't know where they can really go from here. Trials and further development will cost a lot of money, which they don't have.

I bought in at 2.2 and sold at 6.8. I am still holding some but don't like the chances of holding through to development - I think the best chance of a profit here now is a takeover before they go bust - a fire sale of their IP is not an attractive option.
 
PRR is on fire as the day is closing; up 42% as I write to 47c, no, now 48c, on volume. No news of course...
 
Top